Cargando…

Preclinical toxicity and pharmacokinetics of a new orally bioavailable flubendazole formulation and the impact for clinical trials and risk/benefit to patients

BACKGROUND: Flubendazole, originally developed to treat infections with intestinal nematodes, has been shown to be efficacious in animal models of filarial infections. For treatment of filarial nematodes, systemic exposure is needed. For this purpose, an orally bioavailable amorphous solid dispersio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lachau-Durand, Sophie, Lammens, Lieve, van der Leede, Bas-jan, Van Gompel, Jacky, Bailey, Graham, Engelen, Marc, Lampo, Ann
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6334931/ https://www.ncbi.nlm.nih.gov/pubmed/30650076 http://dx.doi.org/10.1371/journal.pntd.0007026

Ejemplares similares

Efficacy of subcutaneous doses and a new oral amorphous solid dispersion formulation of flubendazole on male jirds (Meriones unguiculatus) infected with the filarial nematode Brugia pahangi
por: Fischer, Chelsea, et al.
Publicado: (2019)

Macrofilaricidal efficacy of single and repeated oral and subcutaneous doses of flubendazole in Litomosoides sigmodontis infected jirds
por: Hübner, Marc P., et al.
Publicado: (2019)

Exploring flubendazole formulations for use in sheep. Pharmacokinetic evaluation of a cyclodextrin-based solution
por: Ceballos, Laura, et al.
Publicado: (2012)

Evaluation of Three Amorphous Drug Delivery Technologies to Improve the Oral Absorption of Flubendazole
por: Vialpando, Monica, et al.
Publicado: (2016)

Safety, Tolerability, and Pharmacokinetics of JNJ-1802, a Pan-serotype Dengue Direct Antiviral Small Molecule, in a Phase 1, Double-Blind, Randomized, Dose-Escalation Study in Healthy Volunteers
por: Ackaert, Oliver, et al.
Publicado: (2023)

Pharmacokinetic comparison of different flubendazole formulations in pigs: A further contribution to its development as a macrofilaricide molecule
por: Ceballos, L., et al.
Publicado: (2015)

Toxicity of anthelmintic drugs (fenbendazole and flubendazole) to aquatic organisms
por: Wagil, Marta, et al.
Publicado: (2014)

Genotoxicity of flubendazole and its metabolites in vitro and the impact of a new formulation on in vivo aneugenicity
por: Tweats, David J., et al.
Publicado: (2016)

Genotoxicity of flubendazole and its metabolites in vitro and the impact of a new formulation on in vivo aneugenicity
por: Tweats, David J, et al.
Publicado: (2018)

Flubendazole as a macrofilaricide: History and background
por: Geary, Timothy G., et al.
Publicado: (2019)

The Bioavailability and Pharmacokinetics of Silymarin SMEDDS Formulation Study in Healthy Thai Volunteers
por: Sornsuvit, Chuleegone, et al.
Publicado: (2018)

Development of a Novel Formulation That Improves Preclinical Bioavailability of Tenofovir Disoproxil Fumarate
por: Watkins, Melynda E., et al.
Publicado: (2017)

Thymoquinone-entrapped chitosan-modified nanoparticles: formulation optimization to preclinical bioavailability assessments
por: Rahat, Iqra, et al.
Publicado: (2021)

Preclinical Pharmacokinetics and Bioavailability of Oxypeucedanin in Rats after Single Intravenous and Oral Administration
por: Zheng, Ming-Cong, et al.
Publicado: (2022)

Pharmacology, Toxicity, Bioavailability, and Formulation of Magnolol: An Update
por: Lin, Yiping, et al.
Publicado: (2021)

Testing of acetaminophen in support of the international multilaboratory in vivo rat Pig‐a assay validation trial
por: van der Leede, Bas‐jan, et al.
Publicado: (2020)

Bioavailability and pharmacokinetic comparison of tanshinones between two formulations of Salvia miltiorrhiza in healthy volunteers
por: Xing, Lu, et al.
Publicado: (2017)

Pharmacokinetic Profile and Oral Bioavailability of Diosgenin, Charantin, and Hydroxychalcone From a Polyherbal Formulation
por: Salunkhe, Ruchira, et al.
Publicado: (2021)

Preclinical and Clinical In Vitro In Vivo Correlation of an hGH Dextran Microsphere Formulation
por: Vlugt-Wensink, K. D. F., et al.
Publicado: (2007)

Preclinical Pharmacokinetic Evaluation of β-Lapachone: Characteristics of Oral Bioavailability and First-Pass Metabolism in Rats
por: Kim, Iksoo, et al.
Publicado: (2015)

Flubendazole Plays an Important Anti-Tumor Role in Different Types of Cancers
por: Chen, Chaoran, et al.
Publicado: (2022)

Flubendazole inhibits PD-1 and suppresses melanoma growth in immunocompetent mice
por: Li, Yue, et al.
Publicado: (2023)

Pharmacokinetics and Relative Bioavailability of Orally Administered Innovator‐Formulated Itraconazole Capsules and Solution in Healthy Dogs
por: Hasbach, A.E., et al.
Publicado: (2017)

Flubendazole, FDA-approved anthelmintic, targets breast cancer stem-like cells
por: Hou, Zhi-Jie, et al.
Publicado: (2015)

Profiling the macrofilaricidal effects of flubendazole on adult female Brugia malayi using RNAseq
por: O'Neill, Maeghan, et al.
Publicado: (2016)

Flubendazole demonstrates valid antitumor effects by inhibiting STAT3 and activating autophagy
por: Lin, Shichong, et al.
Publicado: (2019)

Pharmacokinetics of a Prototype Formulation of Sublingual Testosterone and a Buspirone Tablet, Versus an Advanced Combination Tablet of Testosterone and Buspirone in Healthy Premenopausal Women
por: van Rooij, Kim, et al.
Publicado: (2014)

Mycophenolic Acid for Topical Immunosuppression in Vascularized Composite Allotransplantation: Optimizing Formulation and Preliminary Evaluation of Bioavailability and Pharmacokinetics
por: Feturi, Firuz G., et al.
Publicado: (2018)

Activity of a Long-Acting Injectable Bedaquiline Formulation in a Paucibacillary Mouse Model of Latent Tuberculosis Infection
por: Kaushik, Amit, et al.
Publicado: (2019)

Exploring the Potential of Flubendazole in Filariasis Control: Evaluation of the Systemic Exposure for Different Pharmaceutical Preparations
por: Ceballos, Laura, et al.
Publicado: (2014)

An In Vitro/In Vivo Model to Analyze the Effects of Flubendazole Exposure on Adult Female Brugia malayi
por: O’Neill, Maeghan, et al.
Publicado: (2016)

Identification of flubendazole as potential anti-neuroblastoma compound in a large cell line screen
por: Michaelis, Martin, et al.
Publicado: (2015)

Preclinical Safety and Pharmacokinetics of Heat Stable Oxytocin in Sublingual Fast-Dissolving Tablet Formulation
por: Zhu, Changcheng, et al.
Publicado: (2022)

Pharmacokinetics and bioavailability study of two ondansetron oral soluble film formulations in fasting healthy male Chinese volunteers
por: Zhu, Yubing, et al.
Publicado: (2015)

Comparative Bioavailability and Pharmacokinetics Between the Solid Form of Metformin vs a Novel Liquid Extemporaneous Formulation in Children
por: Alemón-Medina, Radamés, et al.
Publicado: (2021)

Swine as the Animal Model for Testing New Formulations of Anti-Inflammatory Drugs: Carprofen Pharmacokinetics and Bioavailability of the Intramuscular Route
por: Gómez-Segura, Lidia, et al.
Publicado: (2022)

Bioavailability and pharmacokinetics of oral meloxicam in llamas
por: Kreuder, Amanda J, et al.
Publicado: (2012)

Pharmacokinetics, bioavailability, and excretion of ponazuril in piglets
por: Wang, Wenxiang, et al.
Publicado: (2022)

Fulvestrant-3-Boronic Acid (ZB716) Demonstrates Oral Bioavailability and Favorable Pharmacokinetic Profile in Preclinical ADME Studies
por: Liu, Jiawang, et al.
Publicado: (2021)

Benefits and Toxicity of Disulfiram in Preclinical Models of Nephropathic Cystinosis
por: Taranta, Anna, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_p1qpgqr2vkpf30sh19q8e8136l